- Latest week
- 10 Jul 2026
- Close
- 11.300000
- Fair value
- 10.411810
- Next-week expectancy
- Undecided 50.24%
PNVL3 Chart Pack
Dimed S.A. Distribuidora de Medicamentos
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, PNVL3 fell 17.76%, moving from 13.74 to 11.30. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 4 of the last 12 weeks. Relative Strength is -8.99 and has softened across the 12-week window. Market Dynamics is -1.12 on the latest week. Next-week expectancy is undecided at 50.24% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 11.30
- 12-Week Change
- -17.76%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 50.24%
- Signal Weeks
- 4 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- -8.99
- Market Dynamics
- -1.12
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 11.30
- 12-Week Change
- -17.76%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 50.24%
- Signal Weeks
- 4 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- -8.99
- Market Dynamics
- -1.12
Over the latest 12 completed weeks ending 2026-07-10, PNVL3 fell 17.76%, moving from 13.74 to 11.30. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 4 of the last 12 weeks. Relative Strength is -8.99 and has softened across the 12-week window. Market Dynamics is -1.12 on the latest week. Next-week expectancy is undecided at 50.24% based on similar historical setup states.
Industry Peers
Brazil equities in Drug Manufacturers - General
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| GILD34 Gilead Sciences, Inc. | SAO | 10 Jul 2026 | 331.92 | 349.20 | 330.78 | 332.38 | 0.14% |
| PFIZ34 Pfizer Inc. | SAO | 10 Jul 2026 | 31.35 | 31.42 | 30.45 | 31.17 | -0.57% |
| G1SK34 GSK plc | SAO | 10 Jul 2026 | 55.44 | 55.86 | 54.84 | 55.05 | -0.70% |
| AMGN34 Amgen Inc. | SAO | 10 Jul 2026 | 67.25 | 67.62 | 66.05 | 66.18 | -1.59% |
| MRCK34 Merck & Co., Inc. | SAO | 10 Jul 2026 | 83.02 | 83.74 | 78.39 | 80.38 | -3.18% |
| LILY34 Eli Lilly and Company | SAO | 10 Jul 2026 | 209.50 | 214.47 | 201.21 | 202.55 | -3.32% |
| JNJB34 Johnson & Johnson | SAO | 10 Jul 2026 | 90.59 | 92.41 | 86.90 | 87.40 | -3.52% |
| N1VS34 Novartis AG | SAO | 10 Jul 2026 | 81.92 | 81.92 | 78.72 | 78.72 | -3.91% |
| N1VO34 Novo Nordisk A/S | SAO | 10 Jul 2026 | 33.00 | 33.00 | 30.86 | 31.62 | -4.18% |
| BIIB34 Biogen Inc. | SAO | 10 Jul 2026 | 181.70 | 181.70 | 170.34 | 170.34 | -6.25% |
| ABBV34 AbbVie Inc. | SAO | 10 Jul 2026 | 85.49 | 85.49 | 77.92 | 78.96 | -7.64% |
| A1ZN34 AstraZeneca PLC | SAO | 10 Jul 2026 | 164.21 | 165.99 | 146.25 | 146.50 | -10.78% |